Trends in Heart Failure Hospitalizations in the US from 2008 to 2018

被引:61
作者
Clark, Katherine A. A. [1 ]
Reinhardt, Samuel W. [1 ]
Chouairi, Fouad [2 ]
Miller, P. Elliott [1 ]
Kay, Bradley [1 ]
Fuery, Michael [3 ]
Guha, Avirup [4 ,5 ]
Ahmad, Tariq [1 ]
Desai, Nihar R. [1 ,6 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[4] Case Western Reserve Univ, Harrington Heart & Vasc Inst, Cleveland, OH 44106 USA
[5] Ohio State Univ, Div Cardiol, Cardiooncol Program, Med Ctr, Columbus, OH 43210 USA
[6] Ctr Outcomes Res & Evaluat, 1 Church St,Suite 200, New Haven, CT 06510 USA
关键词
Heart failure; outcomes; Heart Failure with Reduced Ejection Fraction; Heart Failure with Preserved Ejection Fraction; PRESERVED EJECTION FRACTION; PREVALENCE; COSTS;
D O I
10.1016/j.cardfail.2021.08.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure (HF) is a major driver of health care costs in the United States and is increasing in prevalence. There is a paucity of contemporary data examining trends among hospitalizations for HF that specifically compare HF with reduced or preserved ejection fraction (HFrEF or HFpEF, respectively). Methods and Results: Using the National Inpatient Sample, we identified 11,692,995 hospitalizations due to HF. Hospitalizations increased from 1,060,540 in 2008 to 1,270,360 in 2018. Over time, the median age of patients hospitalized because of HF decreased from 76.0 to 73.0 years (P < 0.001). There were increases in the proportions of Black patients (18.4% in 2008 to 21.2% in 2018) and of Hispanic patients (7.1% in 2008 to 9.0% in 2018; P < 0.001, all). Over the study period, we saw an increase in comorbid diabetes, sleep apnea and obesity (P < 0.001, all) in the entire cohort with HF as well as in the HFrEF and HFpEF subgroups. Persons admitted because of HFpEF were more likely to be white and older compared to admissions because of HFrEF and also had lower costs. Inpatient mortality decreased from 2008 to 2018 for overall HF (3.3% to 2.6%) and HFpEF (2.4% to 2.1%; P < 0.001, all) but was stable for HFrEF (2.8%, both years). Hospital costs, adjusted for inflation, decreased in all 3 groups across the study period, whereas length of stay was relatively stable over time for all groups. Conclusions: The volume of patients hospitalized due to HF has increased over time and across subgroups of ejection fraction. The demographics of HF, HFrEF and HFpEF have become more diverse over time, and hospital inpatient costs have decreased, regardless of HF type. Inpatient mortality rates improved for overall HF and HFpEF admissions but remained stable for HFrEF admissions.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 25 条
  • [1] National Trends in Admission and In-Hospital Mortality of Patients With Heart Failure in the United States (2001-2014)
    Akintoye, Emmanuel
    Briasoulis, Alexandros
    Egbe, Alexander
    Dunlay, Shannon M.
    Kushwaha, Sudhir
    Levine, Diane
    Afonso, Luis
    Mozaffarian, Dariush
    Weinberger, Jarrett
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):
  • [2] Epidemiology of Heart Failure with Preserved Ejection Fraction
    Andersson, Charlotte
    Vasan, Ramachandran S.
    [J]. HEART FAILURE CLINICS, 2014, 10 (03) : 377 - +
  • [3] Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos S.
    Jamal, Waheed
    Salsali, Afshin
    Schnee, Janet
    Kimura, Karen
    Zeller, Cordula
    George, Jyothis
    Brueckmann, Martina
    Zannad, Faiez
    Packer, Milton
    Packer, Milton
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos S.
    Zannad, Faiez
    George, Jyothis
    Brueckmann, Martina
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (10) : 1279 - 1287
  • [4] [Anonymous], 2020, DAPAGLIFLOZIN EVALUA
  • [5] Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
    Benjafield, Adam V.
    Ayas, Najib T.
    Eastwood, Peter R.
    Heinzer, Raphael
    Ip, Mary S. M.
    Morrell, Mary J.
    Nunez, Carlos M.
    Patel, Sanjay R.
    Penzel, Thomas
    Pepin, Jean-Louis D.
    Peppard, Paul E.
    Sinha, Sanjeev
    Tufik, Sergio
    Valentine, Kate
    Malhotra, Atul
    [J]. LANCET RESPIRATORY MEDICINE, 2019, 7 (08) : 687 - 698
  • [6] Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance
    Chang, Patricia P.
    Wruck, Lisa M.
    Shahar, Eyal
    Rossi, Joseph S.
    Loehr, Laura R.
    Russell, Stuart D.
    Agarwal, Sunil K.
    Konety, Suma H.
    Rodriguez, Carlos J.
    Rosamond, Wayne D.
    [J]. CIRCULATION, 2018, 138 (01) : 12 - 24
  • [7] Ageing, demographics, and heart failure
    Coats, Andrew J. Stewart
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0L) : L4 - L7
  • [8] Freedman David S., 2011, Morbidity and Mortality Weekly Report, V60, P73
  • [9] Trends of Clinical Outcomes and Health Care Resource Use in Heart Failure in the United States
    Khan, Safi U.
    Khan, Muhammad Zia
    Alkhouli, Mohamad
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (14):
  • [10] Health Status Disparities by Sex, Race/Ethnicity, and Socioeconomic Status in Outpatients With Heart Failure
    Khariton, Yevgeniy
    Nassif, Michael E.
    Thomas, Lathe
    Fonarow, Gregg C.
    Mi, Xiaojuan
    DeVore, Adam D.
    Duffy, Carol
    Sharma, Puza P.
    Albert, Nancy M.
    Patterson, J. Herbert
    Butler, Laved
    Hernandez, Adrian F.
    Williams, Fredonia B.
    McCague, Kevin
    Spertus, John A.
    [J]. JACC-HEART FAILURE, 2018, 6 (06) : 465 - 473